Resalis Therapeutics logo

Resalis Therapeutics

Healthcare & Life Sciences

Recent Finacing

Equity

Recent Raise

Undisclosed


Resalis Therapeutics is a biotechnology company developing an antisense oligonucleotide treatment for obesity by targeting metabolic pathways.

Total Funding

Undisclosed

Headquarters

Torino, Italy

Founded

N/A

Focus Areas

Antisense oligonucleotide
miR-22
obesity treatment
metabolic pathways
clinical trial.

Investors

Sanofi logo